DocMorris AG (DOCM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DocMorris AG (DOCM) has a cash flow conversion efficiency ratio of -0.116x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-55.66 Million ≈ $-70.36 Million USD) by net assets (CHF480.35 Million ≈ $607.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DOCM market cap for the company's overall valuation and market capitalisation.
DocMorris AG - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how DocMorris AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
DocMorris AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DocMorris AG ranked by their cash flow conversion efficiency. Explore how high is DocMorris AG's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
New Power Plasma Co.Ltd
KQ:144960
|
0.051x |
|
Global Indemnity Group, LLC Class A Common Stock
NASDAQ:GBLI
|
0.000x |
|
Gigasolar Materials
TWO:3691
|
-0.036x |
|
WATERDROP INC.ADS/10 CL.A
F:717
|
N/A |
|
Jiangsu Fengshan Group Co Ltd
SHG:603810
|
-0.013x |
|
Zhejiang Linuo Flow Control Techno
SHE:300838
|
-0.068x |
|
First United Corporation
NASDAQ:FUNC
|
0.023x |
|
Anora Group Oyj
HE:ANORA
|
0.266x |
Annual Cash Flow Conversion Efficiency for DocMorris AG (2010–2024)
The table below shows the annual cash flow conversion efficiency of DocMorris AG from 2010 to 2024. View DOCM share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CHF340.11 Million ≈ $430.00 Million |
CHF-26.60 Million ≈ $-33.63 Million |
-0.078x | +61.48% |
| 2023-12-31 | CHF430.53 Million ≈ $544.31 Million |
CHF-87.42 Million ≈ $-110.52 Million |
-0.203x | +26.79% |
| 2022-12-31 | CHF350.78 Million ≈ $443.48 Million |
CHF-97.29 Million ≈ $-123.00 Million |
-0.277x | -2.96% |
| 2021-12-31 | CHF484.92 Million ≈ $613.07 Million |
CHF-130.63 Million ≈ $-165.15 Million |
-0.269x | -112.18% |
| 2020-12-31 | CHF531.74 Million ≈ $672.26 Million |
CHF-67.51 Million ≈ $-85.35 Million |
-0.127x | +37.64% |
| 2019-12-31 | CHF405.54 Million ≈ $512.71 Million |
CHF-82.57 Million ≈ $-104.39 Million |
-0.204x | -171.83% |
| 2018-12-31 | CHF443.61 Million ≈ $560.84 Million |
CHF-33.23 Million ≈ $-42.01 Million |
-0.075x | +0.85% |
| 2017-12-31 | CHF294.22 Million ≈ $371.98 Million |
CHF-22.23 Million ≈ $-28.10 Million |
-0.076x | +43.30% |
| 2016-12-31 | CHF103.81 Million ≈ $131.24 Million |
CHF-13.83 Million ≈ $-17.48 Million |
-0.133x | -151.38% |
| 2015-12-31 | CHF72.78 Million ≈ $92.01 Million |
CHF18.87 Million ≈ $23.86 Million |
0.259x | +178.59% |
| 2014-12-31 | CHF77.35 Million ≈ $97.79 Million |
CHF7.20 Million ≈ $9.10 Million |
0.093x | +240.84% |
| 2013-12-31 | CHF73.38 Million ≈ $92.77 Million |
CHF2.00 Million ≈ $2.53 Million |
0.027x | -88.74% |
| 2012-12-31 | CHF85.79 Million ≈ $108.46 Million |
CHF20.81 Million ≈ $26.31 Million |
0.243x | +607.10% |
| 2011-12-31 | CHF81.80 Million ≈ $103.42 Million |
CHF2.81 Million ≈ $3.55 Million |
0.034x | -80.54% |
| 2010-12-31 | CHF79.19 Million ≈ $100.12 Million |
CHF13.96 Million ≈ $17.65 Million |
0.176x | -- |
About DocMorris AG
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. It offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insu… Read more